HFM Investment Advisors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65K Buy
11
+5
+83% +$544 ﹤0.01% 532
2026
Q1
$554 Hold
6
﹤0.01% 636
2025
Q4
$613 Buy
6
+2
+50% +$179 ﹤0.01% 639
2025
Q3
$250 Sell
4
-1
-20% -$54 ﹤0.01% 924
2025
Q2
$260 Buy
5
+4
+400% +$179 ﹤0.01% 901
2025
Q1
$43 Buy
+1
New +$43 ﹤0.01% 1080

Other funds holding GH

HFM Investment Advisors's GH Position: Q2 2026 in Review

HFM Investment Advisors increased its Guardant Health (GH) stake by 83% in Q2 2026, buying an estimated $544 and bringing the position to 11 shares worth $1.65K. The position accounts for ﹤0.01% of the portfolio, ranked #532.

HFM Investment Advisors first reported a position in GH in Q1 2025 and has held it in 6 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • HFM Investment Advisors held 11 shares of Guardant Health worth $1.65K as of Q2 2026.
  • HFM Investment Advisors bought 5 Guardant Health shares in Q2 2026, an estimated $544.
  • Guardant Health made up ﹤0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #532 holding.
  • HFM Investment Advisors first reported a position in Guardant Health in Q1 2025 and has held it in 6 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.